Navigation Links
Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
Date:12/10/2012

nificant proportion of patients don't respond to current therapy and these treatments have dose-limiting side effects. As a result, EMA401 is being developed as a potential first-in-class oral treatment for chronic pain, including neuropathic pain, without central nervous system side effects.

Spinifex Pharmaceuticals CEO Tom McCarthy said: "Today's announcement marks another significant step in the development of EMA401 and for Spinifex. Our recent results for EMA401 in PHN served to highlight its potential as an entirely novel approach for the treatment of neuropathic pain. We look forward to completing this study in a second key indication and to moving EMA401 further towards being an important treatment for broader chronic and neuropathic pain indications."

Lead Investigator, Professor Praveen Anand, said: "The pain associated with CIPN can be extremely debilitating and may affect the quality of life of patients for years, even when the cancer is in remission. Further, CIPN symptoms are a major reason for cancer treatments to be reduced or stopped early. The use of an AT2 receptor antagonist as a treatment for neuropathic pain is a highly innovative approach and, in addition to the strong Phase 2 results already seen by the company, my own group has undertaken non-clinical work which is highly compelling. EMA401 could represent a valuable new option for patients in an area where there is a clear need for new medicines."

As described above EMA401 is an AT2 receptor antagonist. The discovery that AT2 receptor antagonists offer an innovative approach to the treatment of neuropathic and inflammatory pain was originally made by Professor Maree Smith at The University of Queensland. Having acquired the technology, Spinifex has conducted a comprehensive pre-clinical and early clinical development program on EMA401. Spinifex continues to conduct research into the role of the AT2 receptor in nociceptive, inf
'/>"/>

SOURCE Spinifex Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Seahorse Bioscience Announces Asia Mito 2012 Travel Award Winners Advancing Cell Metabolism Research
2. Blue Belt Technologies Announces Golden Jubilee National Hospital Completes Initial NavioPFS Unicondylar Knee Replacement Surgery
3. Northwest Biotherapeutics Announces Public Offering of Common Stock and Warrants, and Listing on NASDAQ
4. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. PTC Therapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in Duchenne Muscular Dystrophy
6. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
7. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
8. Cerecor Announces Option to Johns Hopkins Brain Science Institute DAAO Inhibitor Platform
9. Savient Announces the Election of Robert G. Savage to its Board of Directors
10. Harrington Discovery Institute at University Hospitals Case Medical Center Announces Grant Funding to Physician-Scientists at Major Academic Medical Centers to Support New Drug Development
11. Braincells, Inc. Announces the Successful Completion of a Multiple Ascending Dose Study of BCI-838, a Group II mGluR2/3 Antagonist, and the Companys Plans for a Proof-of-Concept Study in Patients with Treatment-Resistant Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015 International Isotopes Inc. (OTCQB: ... year ended December 31, 2014.  The Company reports a ... loss, and positive cash flow for the year ended ... in 2014 was approximately $7.5 million compared to approximately ... approximately 10%.  With the exception of the radiological services ...
(Date:4/1/2015)... 2015 LifeScienceIndustryResearch.com announces ... Industry and 2015 Deep Research Report on ... Pharmaceutical category in its database.  ... basic information, including definition, classification, application, industry ... news analysis, etc. Azithromycin Key Manufacturers Analysis ...
(Date:4/1/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Glucose Clamp Study. The study will be performed at ... San Antonio and University Health System,s ... Ralph DeFronzo . The glucose clamp is ...
Breaking Medicine Technology:International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3
... Reportlinker.com announces that a new market research report is available ... http://www.reportlinker.com/p0324750/Virtual-Pharma.html ... in the pharmaceutical market has slowed – almost to a ... cutting costs in a faltering world economy. ...
... NEW YORK, Nov. 3, 2010 Pfizer Inc. (NYSE: ... public to view and listen to a webcast of ... Primary Care, at the 2010 Annual Credit Suisse Healthcare ... Mountain Standard Time. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ...
Cached Medicine Technology:Reportlinker Adds Virtual Pharma 2Reportlinker Adds Virtual Pharma 3Reportlinker Adds Virtual Pharma 4Reportlinker Adds Virtual Pharma 5Reportlinker Adds Virtual Pharma 6
(Date:4/1/2015)... April 01, 2015 EB Medicine, ... Pediatric Emergency Medicine Practice, and Hospital Medicine Practice, ... with AgileMD to provide the content from its ... a mobile application format available on iPhones, iPads ... collaboration with AgileMD to develop mobile applications for ...
(Date:4/1/2015)... 2015 The U.S. Department of Health ... 123,000 patients who are waiting for a lifesaving organ ... surprising statistic. , In the “Play Through ... a PGA TOUR golfer and two-time heart transplant recipient, ... become organ donors. He inspires viewers by reminding ...
(Date:4/1/2015)... Pricing Healthcare has added facilities to its ... to a third of all US states. The new ... Iowa, and the first dedicated eye center in the country in ... also added. , In addition, the site reached a milestone of ... the platform continue to grow across the country. , 1. ...
(Date:4/1/2015)... Amercanex Corporation, today announced that Native Roots ... and will conduct its wholesale business thru Amercanex proprietary ... as one of the oldest and largest dispensaries in ... in 9 locations with plans of expansion to other ... to have Native Roots join Amercanex as they are ...
(Date:4/1/2015)... April 01, 2015 The term “420” is ... p.m.) when a group of California teenagers would regularly get ... started, 420 has since become a short-hand term for cannabis ... something of a national holiday for the marijuana culture. , ... rapidly-growing group of websites that help bring cannabis businesses and ...
Breaking Medicine News(10 mins):Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 2Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 3Health News:Donate Life America and Genentech have Partnered to Develop the “Play Through with Erik Compton to Donate Life" Public Service Announcement 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 3Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 2Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 3Health News:The WeedLife Network Marks the Marijuana Culture’s 420 Celebrations by Offering Steep Advertising Discounts 2Health News:The WeedLife Network Marks the Marijuana Culture’s 420 Celebrations by Offering Steep Advertising Discounts 3
... May 18 ... USNA ) launched a nationwide geocaching event ... Energy (TM). Rev3 is a tea-based beverage, containing antioxidants ... lift. To view the Multimedia News Release, go to: ...
... -- ACORN CRO, an oncology-focused CRO, has developed ... The introduction of this dedicated technology tool will speed ... feasibility process. "STAR was developed under the guidance of ... valuable time during the study start-up phase. The resulting ...
... 18 Bell Environmental Services (BES) , a ... area, is offering a travel bed bug kit to ... this summer, business travelers and anyone traveling away from ... Bed Bug Kit contains a 6 ounce bed ...
... May 18 AtlantaNAP ( www.atlantanap.com ... client, Health Information Designs.As a strategic initiative to consolidate ... a need for a true Tier III facility, Health ... data center facility for its core operations. The ...
... and Washinton DC (18 May 2009) Research published this ... estimate the annual costs of autism spectrum disorder (ASD) to ... supporting children with ASDs were estimated to be 2.7 billion ... will be presented at the Autism & Employment Workshop taking ...
... Product to Shift Employees to HSA Plans and Cut CostsAMHERST, ... low-cost, customizable platform for employee HSA education. StreetWise HSA ... transition their employees to Health Savings Account plans and cut ... platform that:, , ...
Cached Medicine News:Health News:Photos: USANA Launches National Rev3 Geocaching Challenge 2Health News:ACORN CRO Launches STAR (Site Tracking and Recruitment) 2Health News:Travel Bed Bug Kit Available for 2009 Summer Travel Season 2Health News:GNAX/AtlantaNAP Announces Newest Client, Health Information Designs 2Health News:Autism in the UK costs more than $41 billion every year, shows new research 2Health News:Autism in the UK costs more than $41 billion every year, shows new research 3Health News:StreetWise HSA(SM) Launched Nationally: First Low-Cost, Customizable Platform for Employee HSA Education 2
This blanket is ideal for warming the large child or small adult during upper body surgery....
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: